Literature DB >> 32737434

Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis.

Raphael Szalat1,2, Shayna Sarosiek1,2, Andrea Havasi1,3, Dina Brauneis1,2, J Mark Sloan1,2, Vaishali Sanchorawala4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32737434     DOI: 10.1038/s41375-020-1006-7

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

Review 1.  Cardiac Amyloidosis.

Authors:  Morie A Gertz
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

2.  Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosis.

Authors:  Xiaozhe Li; Beihui Huang; Junru Liu; Meilan Chen; Jingli Gu; Juan Li
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-08       Impact factor: 4.553

3.  Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis.

Authors:  Gareth J Morgan; Joel N Buxbaum; Jeffery W Kelly
Journal:  Hemato       Date:  2021-10-05

4.  Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group.

Authors:  Andrea Havasi; Cihan Heybeli; Nelson Leung; Avital Angel-Korman; Vaishali Sanchorawala; Oliver Cohen; Ashutosh Wechalekar; Frank Bridoux; Insara Jaffer; Victoria Gutgarts; Hani Hassoun; Maya Levinson; Cara Rosenbaum; Paolo Milani; Giovanni Palladini; Giampaolo Merlini; Ute Hegenbart; Stefan Schönland; Kaya Veelken; Alexander Pogrebinsky; Gheorghe Doros; Heather Landau
Journal:  Blood Cancer J       Date:  2022-08-18       Impact factor: 9.812

5.  Detection of minimal residual disease by next generation sequencing in AL amyloidosis.

Authors:  Shayna Sarosiek; Cindy Varga; Allison Jacob; Maria Teresa Fulciniti; Nikhil Munshi; Vaishali Sanchorawala
Journal:  Blood Cancer J       Date:  2021-06-21       Impact factor: 11.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.